298 related articles for article (PubMed ID: 25937098)
21. [Production of Th1/Th2 cytokines and nitric oxide in Behçet's uveitis and idiopathic uveitis].
Guenane H; Hartani D; Chachoua L; Lahlou-Boukoffa OS; Mazari F; Touil-Boukoffa C
J Fr Ophtalmol; 2006 Feb; 29(2):146-52. PubMed ID: 16523155
[TBL] [Abstract][Full Text] [Related]
22. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
Albayrak O; Oray M; Can F; Uludag Kirimli G; Gul A; Tugal-Tutkun I; Onal S
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):52-63. PubMed ID: 30601931
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
24. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
25. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
26. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
Stanford M; Whittall T; Bergmeier LA; Lindblad M; Lundin S; Shinnick T; Mizushima Y; Holmgren J; Lehner T
Clin Exp Immunol; 2004 Jul; 137(1):201-8. PubMed ID: 15196263
[TBL] [Abstract][Full Text] [Related]
27. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease.
Takeno M; Shimoyama Y; Kashiwakura J; Nagafuchi H; Sakane T; Suzuki N
Rheumatol Int; 2004 Jul; 24(4):212-6. PubMed ID: 12879269
[TBL] [Abstract][Full Text] [Related]
28. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
Aktas Cetin E; Cosan F; Cefle A; Deniz G
Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
30. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
31. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir M; Feki M; Hamzaoui K
J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397
[TBL] [Abstract][Full Text] [Related]
32. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease.
Deuter CM; Zierhut M; Möhle A; Vonthein R; Stöbiger N; Kötter I
Arthritis Rheum; 2010 Sep; 62(9):2796-805. PubMed ID: 20518075
[TBL] [Abstract][Full Text] [Related]
33. 4-Octyl Itaconate Inhibits Proinflammatory Cytokine Production in Behcet's Uveitis and Experimental Autoimmune Uveitis.
Wang Q; Ye X; Tan S; Jiang Q; Su G; Pan S; Li H; Cao Q; Yang P
Inflammation; 2024 Jun; 47(3):909-920. PubMed ID: 38183531
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
[TBL] [Abstract][Full Text] [Related]
35. Cytokines and Behcet's disease.
Zhou ZY; Chen SL; Shen N; Lu Y
Autoimmun Rev; 2012 Aug; 11(10):699-704. PubMed ID: 22197901
[TBL] [Abstract][Full Text] [Related]
36. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
[TBL] [Abstract][Full Text] [Related]
37. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
38. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease.
Aridogan BC; Yildirim M; Baysal V; Inaloz HS; Baz K; Kaya S
J Dermatol; 2003 Aug; 30(8):602-7. PubMed ID: 12928529
[TBL] [Abstract][Full Text] [Related]
39. IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease.
Liang L; Tan X; Zhou Q; Zhu Y; Tian Y; Yu H; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):402-14. PubMed ID: 23211828
[TBL] [Abstract][Full Text] [Related]
40. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.
Nagafuchi H; Takeno M; Yoshikawa H; Kurokawa MS; Nara K; Takada E; Masuda C; Mizoguchi M; Suzuki N
Clin Exp Immunol; 2005 Feb; 139(2):363-70. PubMed ID: 15654836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
